Open Orphan wins €4m contract to conduct trial for new RSV treatment - Raglan Capital

Home
About Us
Selected Transactions
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Open Orphan wins €4m contract to conduct trial for new RSV treatment

Home
2020
Open Orphan wins €4m contract to conduct trial for new RSV treatment

Recent News

Open Orphan signs €4.4m contract with global company
Open Orphan wins €4m contract to conduct trial for new RSV treatment
Open Orphan deal to generate ‘significant revenue’ for Venn Life Sciences
Open Orphan signs deal to carry out Covid-19 vaccine trial
Open Orphan agrees contract for Covid-19 vaccine trial
Open Orphan wins contact for Covid-19 vaccine trial

Open Orphan wins €4m contract to conduct trial for new RSV treatment

10th August 2020 | Irish Times

https://www.irishtimes.com/business/health-pharma/open-orphan-wins-4m-contract-to-conduct-trial-for-new-rsv-treatment-1.4326409

Prev
Next

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

© 2020 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences